MUTATIONAL ANALYSIS OF THE DNA HELICASE GENES XPB, XPD, WRN AND BLM IN TUMORS WITH WILD TYPE p53 BUT DEFICIENT IN p53 MEDIATED APOPTOSIS
Loading...
Links to Files
Permanent Link
Author/Creator
Author/Creator ORCID
Date
2000
Department
Hood College Biology
Program
Biomedical and Environmental Science
Citation of Original Publication
Rights
Subjects
Abstract
Cancer is essentially a genetic disease caused by a
defective control of cell proliferation. The P53 gene is
known to regulate the responses of cell growth and death to
genotoxic stimuli and to protect cells from malignant
transformation. Inactivation of P53 is considered to be the
most common genetic event in neoplasms and probably
contributes to over 50% of all human cancers. Most human
cancers show altered growth regulation mediated by two tumor
suppressor proteins, those of the retinoblastoma gene (RB)
and the P53 gene, indicating that the loss of both pathways
is necessary for tumor development. P53 functions in the
cellular response to DNA damage and limits the consequences
of uncontrolled mitogenesis by promoting cell cycle arrest
or apoptosis. The loss of P53 allows the proliferation of
neoplastic cells. DNA helicases function by the biochemical
manipulation of nucleic acids and mutations in genes in this
gene family are associated with several human genetic
disorders. Four genes in this category, XPB and XPD
associated with xeroderma pigmentosum, BLM with Bloom
Syndrome and WRN with Werner Syndrome, were analyzed in
cDNAs derived from tumor cell lines known to be wild type
for the P53 gene. It is known that P53 selectively binds to
and inhibits the DNA helicase activity of transcription
repair complexes and that this activity either modulates DNA
repair efficiency or triggers apoptosis. Experimental
evidence indicates that mutations in these and other DNA
helicase genes could influence P53 mediated apoptosis. The
data collected from these cell lines resulted in the
detection of six polymorphisms of which only two led to an
amino acid change within the gene. It was therefore
concluded that it is most likely that other component(s) of
the p53 pathway are defective in these cells and that the
search for the factors causing a neoplastic response in
cells that have intact p53 function will require additional
research into the factors governing p53 regulation of cell
division.